• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞外 PKCδ 信号通过表皮生长因子受体促进肝癌细胞肿瘤增殖。

Extracellular PKCδ signals to epidermal growth factor receptor for tumor proliferation in liver cancer cells.

机构信息

Department of Biochemistry, The Jikei University School of Medicine, Tokyo, Japan.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

出版信息

Cancer Sci. 2022 Jul;113(7):2378-2385. doi: 10.1111/cas.15386. Epub 2022 May 12.

DOI:10.1111/cas.15386
PMID:35490382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9277411/
Abstract

Protein kinase C delta (PKCδ) is a multifunctional PKC family member and has been implicated in many types of cancers, including liver cancer. Recently, we have reported that PKCδ is secreted from liver cancer cells, and involved in cell proliferation and tumor growth. However, it remains unclear whether the extracellular PKCδ directly regulates cell surface growth factor receptors. Here, we identify epidermal growth factor receptor (EGFR) as a novel interacting protein of the cell surface PKCδ in liver cancer cells. Imaging studies showed that secreted PKCδ interacted with EGFR-expressing cells in both autocrine and paracrine manners. Biochemical analysis revealed that PKCδ bound to the extracellular domain of EGFR. We further found that a part of the amino acid sequence on the C-terminal region of PKCδ was similar to the putative EGFR binding site of EGF. In this regard, the point mutant of PKCδ in the binding site lacked the ability to bind to the extracellular domain of EGFR. Upon an extracellular PKCδ-EGFR association, ERK1/2 activation, downstream of EGFR signaling, was apparently induced in liver cancer cells. This study indicates that extracellular PKCδ behaves as a growth factor and provides a molecular basis for extracellular PKCδ-targeting therapy for liver cancer.

摘要

蛋白激酶 C 亚型 δ(PKCδ)是多功能蛋白激酶 C 家族成员,与多种类型的癌症有关,包括肝癌。最近,我们报道 PKCδ 从肝癌细胞分泌,并参与细胞增殖和肿瘤生长。然而,细胞外 PKCδ 是否直接调节细胞表面生长因子受体仍不清楚。在这里,我们确定表皮生长因子受体(EGFR)是肝癌细胞表面 PKCδ 的一种新型相互作用蛋白。成像研究表明,分泌的 PKCδ 以自分泌和旁分泌的方式与表达 EGFR 的细胞相互作用。生化分析显示 PKCδ 与 EGFR 的细胞外结构域结合。我们进一步发现 PKCδ C 端区域的一部分氨基酸序列与 EGF 的 EGFR 结合位点相似。在这方面,结合位点处 PKCδ 的点突变体缺乏与 EGFR 细胞外结构域结合的能力。细胞外 PKCδ-EGFR 结合后,肝癌细胞中 EGFR 信号下游的 ERK1/2 激活明显增加。这项研究表明,细胞外 PKCδ 具有生长因子的作用,并为肝癌的细胞外 PKCδ 靶向治疗提供了分子基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/f73b155db4c3/CAS-113-2378-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/6cd711b8ebe6/CAS-113-2378-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/098aaccdb53c/CAS-113-2378-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/278094da1804/CAS-113-2378-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/aec8410644b9/CAS-113-2378-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/f73b155db4c3/CAS-113-2378-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/6cd711b8ebe6/CAS-113-2378-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/098aaccdb53c/CAS-113-2378-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/278094da1804/CAS-113-2378-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/aec8410644b9/CAS-113-2378-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b1/9277411/f73b155db4c3/CAS-113-2378-g005.jpg

相似文献

1
Extracellular PKCδ signals to epidermal growth factor receptor for tumor proliferation in liver cancer cells.细胞外 PKCδ 信号通过表皮生长因子受体促进肝癌细胞肿瘤增殖。
Cancer Sci. 2022 Jul;113(7):2378-2385. doi: 10.1111/cas.15386. Epub 2022 May 12.
2
Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.周期性机械应力通过PI3K-Akt和ERK1/2激活大鼠软骨细胞中PKCδ依赖性的表皮生长因子受体(EGFR)促有丝分裂信号。
Cell Physiol Biochem. 2016;39(4):1281-94. doi: 10.1159/000447833. Epub 2016 Sep 8.
3
Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.非传统分泌的蛋白激酶 Cδ 通过刺激肝癌细胞中 ERK1/2 信号通路发挥致癌作用。
Cancer Res. 2021 Jan 15;81(2):414-425. doi: 10.1158/0008-5472.CAN-20-2009. Epub 2020 Dec 14.
4
Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta.表皮生长因子受体信号转导通路的激活刺激蛋白激酶Cδ的酪氨酸磷酸化。
J Biol Chem. 1996 Mar 8;271(10):5325-31. doi: 10.1074/jbc.271.10.5325.
5
Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway.表皮生长因子通过蛋白激酶Cδ依赖性途径诱导成纤维细胞收缩和运动。
J Biol Chem. 2004 Apr 9;279(15):14551-60. doi: 10.1074/jbc.M311981200. Epub 2004 Jan 27.
6
EGF receptor and PKCδ kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases.表皮生长因子受体和蛋白激酶 Cδ激酶通过 ERK 和 MSK1 激酶的双相激活,激活 DNA 损伤诱导的促生存和促凋亡信号。
J Biol Chem. 2019 Mar 22;294(12):4488-4497. doi: 10.1074/jbc.RA118.006944. Epub 2019 Jan 24.
7
Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling.PKCδ 的磷酸化作用由 FER 引发,使平衡从 EGFR 降解转向循环。
J Cell Biol. 2021 Feb 1;220(2). doi: 10.1083/jcb.201902073.
8
Regorafenib suppresses epidermal growth factor receptor signaling-modulated progression of colorectal cancer.regorafenib 抑制表皮生长因子受体信号转导调节的结直肠癌进展。
Biomed Pharmacother. 2020 Aug;128:110319. doi: 10.1016/j.biopha.2020.110319. Epub 2020 Jun 2.
9
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.针对 EGFR 突变型肺癌中 EGFR 抑制剂耐药的异质性机制靶向 PKCδ作为一种治疗策略。
Cancer Cell. 2018 Dec 10;34(6):954-969.e4. doi: 10.1016/j.ccell.2018.11.007.
10
The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.表皮生长因子受体的细胞外结构域。结合亲和力与化学计量学、受体二聚化及结合结构域突变体的研究
Eur J Biochem. 1994 Oct 1;225(1):223-33. doi: 10.1111/j.1432-1033.1994.00223.x.

引用本文的文献

1
Missense variants in PRKCD: elucidating their potential association with breast cancer.蛋白激酶Cδ(PRKCD)中的错义变体:阐明它们与乳腺癌的潜在关联。
Breast Cancer Res. 2025 Jul 28;27(1):139. doi: 10.1186/s13058-025-02090-x.
2
Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma.蛋白激酶Cδ是肝细胞癌的一种新型生物标志物。
Gastro Hep Adv. 2022 Aug 5;2(1):83-95. doi: 10.1016/j.gastha.2022.07.020. eCollection 2023.
3
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations.转录反应对标准 AML 药物的鉴定表明存在协同组合。

本文引用的文献

1
Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.非传统分泌的蛋白激酶 Cδ 通过刺激肝癌细胞中 ERK1/2 信号通路发挥致癌作用。
Cancer Res. 2021 Jan 15;81(2):414-425. doi: 10.1158/0008-5472.CAN-20-2009. Epub 2020 Dec 14.
2
Equivocal, explicit and emergent actions of PKC isoforms in cancer.PKC 同工型在癌症中的模棱两可、明确和新兴作用。
Nat Rev Cancer. 2021 Jan;21(1):51-63. doi: 10.1038/s41568-020-00310-4. Epub 2020 Nov 11.
3
EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma.
Int J Mol Sci. 2023 Aug 18;24(16):12926. doi: 10.3390/ijms241612926.
4
Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma.免疫原性细胞死亡相关长非编码 RNA 影响肺腺癌的免疫治疗。
Oncol Res. 2023 Jul 21;31(5):753-767. doi: 10.32604/or.2023.029287. eCollection 2023.
5
Comprehensive chemical profiling of two Dendrobium species and identification of anti-hepatoma active constituents from Dendrobium chrysotoxum by network pharmacology.采用网络药理学方法对两种铁皮石斛属植物进行全面的化学成分分析,并从铁皮石斛中鉴定出抗肝癌活性成分。
BMC Complement Med Ther. 2023 Jul 1;23(1):217. doi: 10.1186/s12906-023-04048-y.
6
Extended-Synaptotagmin 1 Enhances Liver Cancer Progression Mediated by the Unconventional Secretion of Cytosolic Proteins.延伸突触结合蛋白 1 增强了细胞质蛋白非常规分泌介导的肝癌进展。
Molecules. 2023 May 11;28(10):4033. doi: 10.3390/molecules28104033.
7
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B vesicle pathway in liver cancer.延伸突触结合蛋白 1 通过 SEC22B 囊泡途径参与肝癌的非常规蛋白分泌。
Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2202730119. doi: 10.1073/pnas.2202730119. Epub 2022 Aug 31.
EGFR 和 c-MET 合作增强肝癌对 PARP 抑制剂的耐药性。
Cancer Res. 2019 Feb 15;79(4):819-829. doi: 10.1158/0008-5472.CAN-18-1273. Epub 2018 Dec 20.
4
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer.针对 EGFR 突变型肺癌中 EGFR 抑制剂耐药的异质性机制靶向 PKCδ作为一种治疗策略。
Cancer Cell. 2018 Dec 10;34(6):954-969.e4. doi: 10.1016/j.ccell.2018.11.007.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.细胞表面核仁素作为一种有前景的受体,可实现AS1411适配体介导的有效靶向药物递送至癌细胞。
Curr Drug Deliv. 2018;15(9):1323-1329. doi: 10.2174/1567201815666180724104451.
7
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer.血管生成素/核糖核酸酶 5 是一种表皮生长因子受体配体,也是胰腺癌对厄洛替尼敏感性的血清生物标志物。
Cancer Cell. 2018 Apr 9;33(4):752-769.e8. doi: 10.1016/j.ccell.2018.02.012. Epub 2018 Mar 29.
8
Periodic Mechanical Stress Activates PKCδ-Dependent EGFR Mitogenic Signals in Rat Chondrocytes via PI3K-Akt and ERK1/2.周期性机械应力通过PI3K-Akt和ERK1/2激活大鼠软骨细胞中PKCδ依赖性的表皮生长因子受体(EGFR)促有丝分裂信号。
Cell Physiol Biochem. 2016;39(4):1281-94. doi: 10.1159/000447833. Epub 2016 Sep 8.
9
Cell surface localization of importin α1/KPNA2 affects cancer cell proliferation by regulating FGF1 signalling.输入蛋白α1/KPNA2的细胞表面定位通过调节FGF1信号传导影响癌细胞增殖。
Sci Rep. 2016 Feb 18;6:21410. doi: 10.1038/srep21410.
10
EGFR Signaling in Liver Diseases.肝脏疾病中的表皮生长因子受体信号传导
Int J Mol Sci. 2015 Dec 29;17(1):30. doi: 10.3390/ijms17010030.